These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5961208)

  • 21. The immunologic character of acquired inhibitors of antihemophilic globulin (factor 8) and the kinetics of their interaction with factor 8.
    Shapiro SS
    J Clin Invest; 1967 Feb; 46(2):147-56. PubMed ID: 6018754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hemophilia A: early detection of women carriers by Laurell's quantitative immunoelectrophoresis].
    Biland L; Nyman D; Benz A; Duckert F
    Schweiz Med Wochenschr; 1975 May; 105(19):620-2. PubMed ID: 1080293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.
    Nilsson IM; Berntorp E; Zettervall O
    N Engl J Med; 1988 Apr; 318(15):947-50. PubMed ID: 3127711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunological studies on factor VIII in hemophilia and von Willebrand disease].
    Casillas G; Simonetti C; Pavlovsky A
    Medicina (B Aires); 1977; 37(3):215-22. PubMed ID: 302385
    [No Abstract]   [Full Text] [Related]  

  • 25. Bovine antihaemophilic globulin in the treatment of haemophilia.
    MACFARLANE RG; BIGGS R; BIDWELL E
    Lancet; 1954 Jun; 266(6826):1316-9. PubMed ID: 13164381
    [No Abstract]   [Full Text] [Related]  

  • 26. Antibody response of cattle to Leptospira pomona: a hemagglutination test to measure IgG and IgM antibodies.
    Negi SK; Myers WL; Segre D
    Am J Vet Res; 1971 Dec; 32(12):1907-13. PubMed ID: 5131418
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibodies to factor VIII. 3. Characterization of the immune response to iso- and heteroantigens in hemophilia A.
    Allain JP; Vedrenne J; Frommel D
    Pathol Biol (Paris); 1973 Nov; 21():Suppl:76-9. PubMed ID: 4128454
    [No Abstract]   [Full Text] [Related]  

  • 28. Production of antihemophilic (factor VIII) activity from albumin.
    Barrow EM; Lester RH; Johnson AM; Graham JB
    Am J Physiol; 1972 Apr; 222(4):920-7. PubMed ID: 4537282
    [No Abstract]   [Full Text] [Related]  

  • 29. [Genetic polymorphism of hemophilia A].
    van der Schoot P; Geerdink P; Haanen C
    Ned Tijdschr Geneeskd; 1970 Nov; 114(48):1997-2000. PubMed ID: 5480489
    [No Abstract]   [Full Text] [Related]  

  • 30. The prevalence of proteolytic antibodies against factor VIII in hemophilia A.
    Lacroix-Desmazes S; Bayry J; Misra N; Horn MP; Villard S; Pashov A; Stieltjes N; d'Oiron R; Saint-Remy JM; Hoebeke J; Kazatchkine MD; Reinbolt J; Mohanty D; Kaveri SV
    N Engl J Med; 2002 Feb; 346(9):662-7. PubMed ID: 11870243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A.
    Reipert BM; Ahmad RU; Turecek PL; Schwarz HP
    Thromb Haemost; 2000 Nov; 84(5):826-32. PubMed ID: 11127864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Factor VIII inhibitors--their characteristics and clinical significance].
    Dmoszyńska A; Kniaź M; Sokołowska B
    Pol Arch Med Wewn; 1987 Dec; 78(6):333-40. PubMed ID: 3152083
    [No Abstract]   [Full Text] [Related]  

  • 33. Circulating immune complexes containing anti-VIII antibodies in multi-transfused patients with haemophilia A.
    Kazatchkine MD; Sultan Y; Burton-Kee EJ; Mowbray JF
    Clin Exp Immunol; 1980 Feb; 39(2):315-20. PubMed ID: 6771074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normal factor 8 antigen level in combined congenital deficiency of factor V and factor VIII.
    Girolami A; Bareggi G
    Acta Haematol; 1974; 51(6):362-3. PubMed ID: 4212203
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of factor VIII antibodies.
    Shapiro SS
    Ann N Y Acad Sci; 1975 Jan; 240():350-61. PubMed ID: 46139
    [No Abstract]   [Full Text] [Related]  

  • 36. [Development of a competitive enzyme immunoassay for factor VIII-related antigen].
    Riemer J; Kopperschläger G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(1):72-83. PubMed ID: 6202602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunologic studies in haemophilia A.
    Holmberg L; Nilsson IM
    Scand J Haematol; 1973; 10(1):12-6. PubMed ID: 4702564
    [No Abstract]   [Full Text] [Related]  

  • 38. [Determination of the amount of specific antibodies in precipitated sera and enzymatic cleavage of immune precipitates].
    Baudner S; Haupt H; Schwick HG
    Ann Immunol Hung; 1972; 16(0):65-75. PubMed ID: 4212612
    [No Abstract]   [Full Text] [Related]  

  • 39. Human anti-mouse immunoglobulins in sera of patients treated chronically with monoclonal antibody-purified factor VIII.
    Haimovich J; Davis HM; Schreiber AB
    Semin Hematol; 1990 Apr; 27(2 Suppl 2):11-5. PubMed ID: 2128852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of immune response to mouse IgG in hemophilia A patients treated chronically with Monoclate, a monoclonal antibody affinity purified factor VIII preparation.
    Davis HM; Brown SK; Nash DW; Pennetti AM; Salzman PM; Schreiber AB; Haimovich J
    Thromb Haemost; 1990 Jun; 63(3):386-91. PubMed ID: 2119524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.